NUCLEXPO, created in 2015 (United States), from 5 sister brands and 2214 competing brands. The NUCLEXPO brand is owned by Karyopharm Therapeutics, a company listed in New York. NUCLEXPO is part of the Biotechnology activity sector.
Buy Karyopharm Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
